NASDAQ:ACRX - AcelRx Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$3.22 +0.06 (+1.90 %)
(As of 03/26/2019 01:53 AM ET)
Previous Close$3.16
Today's Range$3.07 - $3.30
52-Week Range$1.99 - $5.05
Volume1.70 million shs
Average Volume2.33 million shs
Market Capitalization$253.60 million
P/E Ratio-3.98
Dividend YieldN/A
Beta2.15

SEC Filings

AcelRx Pharmaceuticals (NASDAQ:ACRX) SEC Filings

DateFilerForm TypeView
03/12/2019
1:15 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2019
4:29 PM
AcelRx Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/07/2019
4:25 PM
AcelRx Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/07/2019
3:05 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/04/2019
3:28 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/04/2019
3:26 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
4:45 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
4:44 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
4:43 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
4:42 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
4:40 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/07/2019
4:33 PM
AcelRx Pharmaceuticals (Issuer)
HOFFMAN STEPHEN J (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
01/11/2019
3:31 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
11:05 AM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/17/2018
11:04 AM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/12/2018
6:31 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/19/2018
5:13 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/15/2018
5:35 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/13/2018
4:18 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/13/2018
4:16 PM
AcelRx Pharmaceuticals (Filer)
Form 424B5
View Filing
11/13/2018
12:53 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/09/2018
6:06 AM
AcelRx Pharmaceuticals (Filer)
Form 424B5
View Filing
11/05/2018
4:29 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
4:24 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
4:23 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
4:21 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
3:50 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
8:23 AM
AcelRx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/02/2018
3:14 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/02/2018
2:05 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/16/2018
3:30 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/16/2018
3:29 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/26/2018
4:54 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
5:08 AM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
5:06 AM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
5:06 AM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
5:06 AM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
3:36 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/06/2018
4:38 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/06/2018
4:23 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/02/2018
4:19 PM
AcelRx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/11/2018
3:18 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/11/2018
3:16 PM
AcelRx Pharmaceuticals (Filer)
Form 424B5
View Filing
07/02/2018
3:51 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/14/2018
5:19 PM
AcelRx Pharmaceuticals (Issuer)
ADAMS ADRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
5:18 PM
AcelRx Pharmaceuticals (Issuer)
Afable Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
5:16 PM
AcelRx Pharmaceuticals (Issuer)
HOFFMAN C STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
5:14 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
5:13 PM
AcelRx Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
5:12 PM
AcelRx Pharmaceuticals (Issuer)
WAN MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/05/2018
4:52 PM
AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/31/2018
10:17 AM
AcelRx Pharmaceuticals (Subject)
LEERINK REVELATION HEALTHCARE FUND I, L.P. (Filed by)
Form SC 13G
View Filing
05/31/2018
10:15 AM
AcelRx Pharmaceuticals (Subject)
Industry Ventures Secondary VIII, L.P. (Filed by)
Form SC 13G
View Filing
05/29/2018
5:52 AM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2018
5:00 PM
AcelRx Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
THREE ARCH ASSOCIATES III LP (Reporting)
THREE ARCH ASSOCIATES IV LP (Reporting)
THREE ARCH PARTNERS III LP (Reporting)
THREE ARCH PARTNERS IV LP (Reporting)
WAN MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/23/2018
4:09 PM
AcelRx Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/23/2018
4:09 PM
AcelRx Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/18/2018
4:07 PM
AcelRx Pharmaceuticals (Issuer)
Saia John G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/18/2018
4:05 PM
AcelRx Pharmaceuticals (Issuer)
Saia John G. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/12/2018
3:31 PM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/27/2018
6:07 AM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
2:38 PM
AcelRx Pharmaceuticals (Subject)
THREE ARCH PARTNERS IV LP (Filed by)
Form SC 13D/A
View Filing
01/26/2018
6:31 PM
AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
6:30 PM
AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
6:29 PM
AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
6:28 PM
AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/26/2018
6:27 PM
AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2017
4:18 PM
AcelRx Pharmaceuticals (Filer)
Form CT ORDER
View Filing
12/19/2017
3:59 PM
AcelRx Pharmaceuticals (Filer)
Form CT ORDER
View Filing
12/04/2017
6:00 AM
AcelRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/30/2017
10:22 AM
AcelRx Pharmaceuticals (Filer)
Form CT ORDER
View Filing
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel